Lower Oxygen Concentration for Preventing Collapsed Lung
(RESPIRA-EIT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether using less oxygen at the end of surgery can prevent a collapsed lung. Typically, patients receive 100% oxygen, but the study examines if 70% or 40% oxygen better prevents lung tissue from collapsing. It targets individuals undergoing planned surgeries with general anesthesia lasting 1 to 5 hours. Researchers will closely monitor participants' breathing and lung health during the trial. The goal is to discover a safer method for managing oxygen use during surgery. As an unphased trial, it allows participants to contribute to significant research that could enhance surgical safety for future patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that this method of using lower oxygen concentration is safe for preventing collapsed lung?
Research has shown that using less oxygen during mechanical ventilation might be safer for the lungs. Studies have found that high oxygen levels can cause parts of the lung to collapse, a condition known as atelectasis. Reducing the oxygen concentration to 70% or 40% may lower this risk.
Previous research suggests that patients with healthy lungs rarely experience complications like a collapsed lung when ventilated. Additionally, using less oxygen generally does not increase the risk of other serious issues. In fact, lower oxygen levels might even reduce the risk of death compared to higher levels.
Overall, using 70% or 40% oxygen appears to be well-tolerated and may decrease certain risks associated with ventilation. It is important to note that both these levels are still higher than normal room air, which contains about 21% oxygen.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores using lower oxygen concentrations to prevent collapsed lungs, offering a potentially safer alternative to the standard practice of using 100% oxygen. By ventilating patients with 40% or 70% oxygen before extubation, this approach might reduce the risk of lung damage associated with high oxygen levels. Current treatments often rely on high oxygen concentrations, which can be harsh on the lungs, so this method could lead to improved patient outcomes with fewer side effects.
What evidence suggests that using lower oxygen concentrations could be effective in preventing collapsed lung during anesthesia?
Studies have shown that using excessive oxygen during anesthesia can cause atelectasis, where part of the lung collapses. This occurs because the lungs take in too much oxygen, leading to deflation. In this trial, participants in the intervention group will receive ventilation with lower oxygen concentrations (either 40% or 70%) during the washout phase before extubation. Research suggests that reducing oxygen levels might lower the risk of atelectasis. Although data on these exact percentages is limited, this approach is based on existing knowledge of lung function. The goal is to keep the lungs open and functioning well without excessive oxygen.16789
Are You a Good Fit for This Trial?
This trial is for adults over 18 who are having elective surgery with general anesthesia and endotracheal intubation, lasting between 1-5 hours. They must consent to participate in the study.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants are randomly assigned to receive either 70% or 100% oxygen concentration during the washout phase before extubation. EIT measurements and other parameters are recorded.
Postoperative Monitoring
Participants are monitored in the PACU for 60 minutes post-extubation, with EIT measurements and SpO2 levels recorded.
Follow-up
Participants are monitored for safety and effectiveness after treatment, including re-intubation or non-invasive ventilation needs within 7 days.
What Are the Treatments Tested in This Trial?
Interventions
- Ventilating the patient with 70% oxygen concentration
Find a Clinic Near You
Who Is Running the Clinical Trial?
Beth Israel Deaconess Medical Center
Lead Sponsor